About Chengwei Capital
Chengwei Capital is a venture capital firm founded in 1999. It is primarily based out of Shanghai, China. As of Jul 2026, Chengwei Capital is an active investor, having invested in 54 companies, with 1 new investment in the last 12 months. It primarily invests in Series B round in China based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Consumer. Most recently it participated in the $***** Seed round of RISC-V Computing Overall, Chengwei Capital portfolio has seen 4 unicorns, 3 IPOs and 4 acquisitions including key companies like SiFive, Youku Tudou and Sila Nanotechnologies. A lot of funds co-invest with Chengwei Capital, with names like Sutter Hill Ventures sharing a substantial percentage of its portfolio. Chengwei Capital has team of 24 people including 11 partners.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 4 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Deals in last 12 months
Chengwei Capital's List of Top Investments
Chengwei Capital has a portfolio of 54 companies, including 4 unicorns. Their most notable investments are in AInnovation and Bolome.Their portfolio spans across China, United States and Germany. They have invested in Enterprise Applications, High Tech, Consumer and 24 other sectors, across stages such as Series A, Series B and 4 more. Here is the list of top investments by Chengwei Capital:1. SiFive
Provider of customizable RISC-V processor IP and high-performance compute core solutions for AI. It delivers scalable and configurable CPU core solutions including scalar, vector, and matrix computing designs. It enables chip designers and system developers to build high-performance, energy-efficient computing solutions across domains such as AI/ML, automotive systems, edge computing, data centers, and embedded devices. It focuses on enabling customization, rapid innovation, and performance optimization through modular processor IP, supporting applications that require flexible compute architectures and advanced workload acceleration.
Key facts about SiFive
- Founded Year: 2015
- Location: Santa Clara (United States)
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $766M
- Employee Count: 509 as on Jul 31, 2026
- Investors: T. Rowe Price, Qualcomm Ventures and 26 Others
- Latest Funding Round: Series G, Apr 09, 2026, $*****
- Highlight: Editors' Pick
2. Youku Tudou
Youku Tudou is a video streaming platform. It uses tri-networks integration model applied on this video-sharing platform that enables users to search, view, and share high-quality video content quickly and easily across multiple devices. Youku Tudou’s offerings are not limited to original user-generated content. Its online video content ranges from user-generated content and self-produced serials to licensed professional content. Offers a space for both individuals and institutions to upload and share their moments, independent films, viral videos, and anything else they create.
Key facts about Youku Tudou
- Founded Year: 2006
- Location: Shanghai (China)
- Stage: Acquired
- Total Funding till date: $110M
- Employee Count: 353 as on Jul 31, 2026
- Investors: Western Technology Investment, Brookside Capital and 14 Others
- Latest Funding Round: Post IPO, Apr 28, 2014, $*****
- Highlight: Acquired
Provider of nanotech-based lithium-ion batteries for diversified applications. It provides uers with a company that has developed a nanomaterial that works as a drop-in replacement for the existing battery manufacturing process. It claims to enable higher energy density in current batteries for multiple areas including wearables, portable electronics, mass adoption of electric vehicles, and the practical use of renewable energy.
Key facts about Sila Nanotechnologies
- Founded Year: 2011
- Location: Alameda (United States)
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $1.61B
- Employee Count: 429 as on Jul 31, 2026
- Investors: T. Rowe Price, Fidelity Investments and 32 Others
- Latest Funding Round: Series G, Jul 21, 2026, $*****
- Highlight: Editors' Pick
4. Tandem AI
AI-based drug discovery tool for researchers. The company offers a proprietary web-based platform to increase the speed of drug discovery and deliver cost-effective opportunities to the global scientific community.
Key facts about Tandem AI
- Founded Year: 2021
- Location: New York (United States)
- Stage: Series A
- Total Funding till date: $82M
- Employee Count: 50 as on Jul 31, 2026
- Investors: F-Prime Capital, Orbimed and 4 Others
- Latest Funding Round: Series A, Nov 14, 2025, $*****
- Highlight: Editors' Pick
5. XAG
Manufacturer of agricultural drones, robots, autopilot consoles, and smart farm systems. The company offers drones for spraying, spreading, field mapping, and logistics. Agricultural rovers are available for plant protection and farm material delivery. The autopilot consoles bring automated steering to tractors. Smart fertigation systems and IoT products extend automation to irrigation and nutrient management.
Key facts about XAG
- Founded Year: 2007
- Location: Tianhe (China)
- Stage: Series C
- Total Funding till date: $248M
- Employee Count: 110 as on Jul 31, 2026
- Investors: SoftBank Vision Fund, Chengwei Capital and 6 Others
- Latest Funding Round: Series C, Sep 25, 2023, $*****
- Highlight: Editors' Pick
Chengwei Capital's Year-on-Year Investment Trends
Chengwei Capital has invested in 54 companies over the last 22 years, with an average of 3 new investments annually in the last 10 years. In 2025, it made 1 investment, while as of Jul 2026, it has made 2 investments in this year. Its most recent first time investment was in RISC-V Computing and most recent follow-on round was in Full-Life Technologies.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 0 | 1 | 1 |
2024 | 1 | 1 | 2 |
2023 | 3 | 0 | 3 |
2022 | 5 | 0 | 5 |
2021 | 5 | 0 | 5 |
2020 | 1 | 0 | 1 |
2019 | 1 | 4 | 5 |
2018 | 4 | 3 | 7 |
2017 | 8 | 2 | 10 |
Chengwei Capital's Investments by Stage
Chengwei Capital has made 20 investments in Series A stage with an average round size of $20M, 15 investments in Series B stage with an average round size of $25.5M and 11 investments in Seed stage with an average round size of $9.26M.Stage of entry | No. of Investments |
|---|---|
Series A | 20 |
Series B | 15 |
Seed | 11 |
Series C | 5 |
Angel | 2 |
Others | 1 |
Note: We have considered here, only first round of investments
Chengwei Capital's Investments by Sector
Chengwei Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, High Tech, Retail and Media & Entertainment. Notably, it has invested in 47 Tech companies, 28 Enterprise (B2B) companies, 21 Consumer (B2C) companies and at least 19 companies focusing on Software.Sector | No. of Investments |
|---|---|
Enterprise Applications | 17 |
Consumer | 16 |
High Tech | 9 |
Retail | 8 |
Media & Entertainment | 7 |
Others | 57 |
Note: We have considered here, only first round of investments
Chengwei Capital's Investments by Geography
Chengwei Capital has made most investments in China (43), followed by United States where it has made 9 investments.Country | No. of Investments |
|---|---|
China | 43 |
United States | 9 |
Germany | 1 |
Note: We have considered here, only first round of investments
Chengwei Capital's recent investments
Chengwei Capital has made 2 investments in 2026 so far - RISC-V Computing and Full-Life Technologies.Here are the most recent investments by Chengwei Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 10, 2026 | China | Seed | 8223 | ||
May 18, 2026 | China | Series D | 6716 | [+7] | |
Sep 30, 2025 | China | Series C | 5026 | [+7] | |
Oct 25, 2024 | China | Series A | 8727 | - | |
Jan 03, 2024 | China | Series B | 6918 | [+5] |
Unicorns in Chengwei Capital's Portfolio
Chengwei Capital has 4 unicorns in its portfolio - SiFive, Sila Nanotechnologies, DotC United Group and others. The most recent unicorn in their portfolio is SiFive. It became a unicorn in 2022, 3 years after Chengwei Capital first invested in it.Here is a list of unicorns in Chengwei Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
71 | Provider of customizable RISC-V processor IP and high-performance compute core solutions for AI | 2015 | Santa Clara | Series G | bpsqax{ | ||
65 | Provider of nanotech-based lithium-ion batteries for diversified applications | 2011 | Alameda | Series G | q{hqksr | ||
56 | - | 2015 | Shanghai | Series B | itnjkec | ||
51 | Developer of mobile apps related to mobile personalization | 2014 | Beijing | Series C | kbyqwpw |
IPOs and Publicly Listed companies in Chengwei Capital's Portfolio
3 of Chengwei Capital's portfolio companies have become public. AInnovation got listed on the Hong Kong Exchanges (HKG), in Jan 2022 at marketcap of $1.96B and Qutoutiao got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $84M.Here are Chengwei Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 26, 2022 | May 2018 | Seed | 5939 | |
Sep 13, 2018 | 2017 | Series A | 8269 | |
Oct 31, 2013 | Jan 2010 | Series A | 6935 |
Acquired companies in Chengwei Capital's Portfolio
4 companies from Chengwei Capital's portfolio have been acquired. The most recent acquisition was Sensely in Jun 2024 by Mediktor for $*****.Here are Chengwei Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 04, 2024 | Feb 14, 2017 | Series B | 9414 | |
Feb 26, 2021 | Oct 19, 2016 | Series A | 3245 | |
Oct 16, 2015 | Dec 12, 2006 | Series B | 6608 | |
May 15, 2015 | May 10, 2011 | Series C | 9939 |
Team profile of Chengwei Capital
Chengwei Capital has a team of 24 members including 11 Partners and 4 Principals located in China, United States and 2 more locations. Chengwei Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Chengwei Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | ||
Partner | Jing an | - | ||
Partner | China | - | - | |
Partner | China | - | ||
Partner | Colombia | - | ||
Partner | - | - | - | |
Partner | Shanghai | - | ||
Partner | New York City | - | ||
Partner | China | - | - | |
Partner | China | - | - | |
Partner | Boston | - |
Co-investors of Chengwei Capital
Over the past 22 years, 243 investors have co-invested in Chengwei Capital's portfolio companies. This includes only funds.
- Invested before Chengwei Capital: Matrix Partners China, Source Code Capital and 43 others have invested in rounds before Chengwei Capital. There are 4 companies where Matrix Partners China has invested before Chengwei Capital and 3 companies where Source Code Capital has invested before Chengwei Capital.
- Top Co-investors of Chengwei Capital: 71 investors entered a company along with Chengwei Capital. These include investors like Sutter Hill Ventures (2 companies).
- Invested after Chengwei Capital: A total of 127 investors have invested in Chengwei Capital's portfolio after their investments. Top Investors include Alibaba Group (3 companies), Coatue (2 companies) and Prosperity7 Ventures (2 companies).
Recent News related to Chengwei Capital
•
Full-Life Technologies Secures $150 Million Financing for Clinical Development and ManufacturingPR Newswire•May 19, 2026•Full-Life Technologies, TSG Capital, HSG, Junson Capital and 7 others
•
Full-Life Technologies Announces US$77 Million Financing to Accelerate Radiopharmaceutical DevelopmentPR Newswire•Sep 30, 2025•Junson Capital, Full-Life Technologies, Gordian Ventures, HSG and 5 others
•
•
•
Perpetual Medicines Raises $8M in Seed FundingFinSMEs•Dec 01, 2023•Perpetual Medicines, Chengwei Capital
•
•
•
•
•
